Tech Company Financing Transactions
RoslinCT Funding Round
On 10/6/2026, RoslinCT raised $9.5 million in funding from Scottish Enterprise.
Transaction Overview
Company Name
Announced On
10/6/2026
Transaction Type
Debt
Amount
$9,500,000
Round
Undisclosed
Investors
Scottish Enterprise (Adrian Gillespie)
Proceeds Purpose
The investment will help create a more connected manufacturing ecosystem, supporting the development and manufacture of life-changing cell therapies while creating high-value employment opportunities in Scotland.
Company Information
Company Status
Private & Independent
Industry
Life Sciences
Mailing Address
9 Little France Road
Edinburgh, Scotland, EH16 4UX
UK
Edinburgh, Scotland, EH16 4UX
UK
Phone
Website
Email Address
Overview
We are working with our partners to provide new life-saving autologous and allogeneic therapies for patients worldwide. RoslinCT, as one of the first in the world to produce clinical-grade human pluripotent stem cells, has a strong focus on science and innovation. In collaboration with Vertex Pharmaceuticals, RoslinCT developed, from early process development through commercialization, the First CRISPR-Edited Cell Therapy Product, exa-cel for the treatment of sickle cell disease and transfusion-dependent beta-thalassemia.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Geoffrey Hamilton-Fairley
Chairman
Ian McCubbin
Chief Executive Officer
Peter Coleman
Chief Financial Officer
Lee Warren
Chief Operating Officer
Jane Fraser
Chief Operating Officer
Dean Morris
Chief Technical Officer
Kevin Bruce
President
Adam White
VP - Bus. Development
Jessica Carmen
VP - Regulatory Affairs
Kathy Burri
VP - Regulatory Affairs
Gordon Macdonald
Browse more venture capital transactions:
Prev: 10/6/2026: SereNeuro Therapeutics venture capital transaction
Next: 10/6/2026: KymaThera venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. All VC database entries reported here are derived from publicly available VC deal announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs